BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17374990)

  • 1. Therapeutic effect of arsenic trioxide (As2O3) on cervical cancer in vitro and in vivo through apoptosis induction.
    Yu J; Qian H; Li Y; Wang Y; Zhang X; Liang X; Fu M; Lin C
    Cancer Biol Ther; 2007 Apr; 6(4):580-6. PubMed ID: 17374990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of p38 MAPK and JNK in Arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells.
    Kang YH; Lee SJ
    J Cell Physiol; 2008 Oct; 217(1):23-33. PubMed ID: 18412143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of p38 MAPK and JNK in enhanced cervical cancer cell killing by the combination of arsenic trioxide and ionizing radiation.
    Kang YH; Lee SJ
    Oncol Rep; 2008 Sep; 20(3):637-43. PubMed ID: 18695917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice.
    Kinjo K; Kizaki M; Muto A; Fukuchi Y; Umezawa A; Yamato K; Nishihara T; Hata J; Ito M; Ueyama Y; Ikeda Y
    Leukemia; 2000 Mar; 14(3):431-8. PubMed ID: 10720138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stathmin is involved in arsenic trioxide-induced apoptosis in human cervical cancer cell lines via PI3K linked signal pathway.
    Wang X; Ren JH; Lin F; Wei JX; Long M; Yan L; Zhang HZ
    Cancer Biol Ther; 2010 Sep; 10(6):632-43. PubMed ID: 20657188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38, inactivation of ERK and the Ca2+-dependent production of superoxide.
    Iwama K; Nakajo S; Aiuchi T; Nakaya K
    Int J Cancer; 2001 May; 92(4):518-26. PubMed ID: 11304686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
    Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A
    Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of caspase-3 and -9 in arsenic trioxide-mediated apoptosis in PCI-1 head and neck cancer cells.
    Seol JG; Park WH; Kim ES; Jung CW; Hyun JM; Lee YY; Kim BK
    Int J Oncol; 2001 Feb; 18(2):249-55. PubMed ID: 11172589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor efficacy of DMSA modified Fe3O4 magnetic nanoparticles combined with arsenic trioxide and adriamycin in Raji cells.
    Cai X; Cai X; Wang C; Chen B; Hua W; Shen F; Yu L; He Z; Shi Y; Chen Y; Xia G; Bao W; Zhang Y; Wang X
    J Biomed Nanotechnol; 2014 Feb; 10(2):251-61. PubMed ID: 24738333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Bcl-2 partly inhibits apoptosis of human cervical cancer SiHa cells induced by arsenic trioxide.
    Deng Y; Lin C; Zheng J; Fu M; Liang X; Chen J; Xiao P; Wu M
    Chin Med J (Engl); 2000 Jan; 113(1):84-8. PubMed ID: 11775218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of radiation response in human cervical cancer cells in vitro and in vivo by arsenic trioxide (As2O3).
    Chun YJ; Park IC; Park MJ; Woo SH; Hong SI; Chung HY; Kim TH; Lee YS; Rhee CH; Lee SJ
    FEBS Lett; 2002 May; 519(1-3):195-200. PubMed ID: 12023044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic trioxide induces cervical cancer apoptosis, but specifically targets human papillomavirus-infected cell populations.
    Wen X; Li D; Zhang Y; Liu S; Ghali L; Iles RK
    Anticancer Drugs; 2012 Mar; 23(3):280-7. PubMed ID: 22245994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDM2-mediated Inhibitory Effect of Arsenic Trioxide on Small Cell Lung Cancer Cell Line by Degrading Mutant p53.
    Wang YS; Yin JZ; Shi XQ; Zhao XW; Li B; Yang MH
    Anticancer Agents Med Chem; 2023; 23(16):1829-1837. PubMed ID: 37259217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biocompatible arsenic trioxide nanoparticles induce cell cycle arrest by p21(WAF1/CIP1) expression via epigenetic remodeling in LNCaP and PC3 cell lines.
    Jadhav V; Ray P; Sachdeva G; Bhatt P
    Life Sci; 2016 Mar; 148():41-52. PubMed ID: 26883975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic trioxide induces regulated, death receptor-independent cell death through a Bcl-2-controlled pathway.
    Scholz C; Richter A; Lehmann M; Schulze-Osthoff K; Dörken B; Daniel PT
    Oncogene; 2005 Oct; 24(47):7031-42. PubMed ID: 16007134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination treatment with arsenic trioxide and phytosphingosine enhances apoptotic cell death in arsenic trioxide-resistant cancer cells.
    Park MT; Kang YH; Park IC; Kim CH; Lee YS; Chung HY; Lee SJ
    Mol Cancer Ther; 2007 Jan; 6(1):82-92. PubMed ID: 17237268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide induces apoptosis and the formation of reactive oxygen species in rat glioma cells.
    Sun Y; Wang C; Wang L; Dai Z; Yang K
    Cell Mol Biol Lett; 2018; 23():13. PubMed ID: 29610575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis.
    Kitamura K; Minami Y; Yamamoto K; Akao Y; Kiyoi H; Saito H; Naoe T
    Leukemia; 2000 Oct; 14(10):1743-50. PubMed ID: 11021749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic trioxide induces apoptosis in pancreatic cancer cells via changes in cell cycle, caspase activation, and GADD expression.
    Li X; Ding X; Adrian TE
    Pancreas; 2003 Aug; 27(2):174-9. PubMed ID: 12883267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic trioxide inhibits cell proliferation and human papillomavirus oncogene expression in cervical cancer cells.
    Wang H; Gao P; Zheng J
    Biochem Biophys Res Commun; 2014 Sep; 451(4):556-61. PubMed ID: 25117446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.